Undefined Calcinosis Cutis: 5 Types, Signs, And Diagnosis
Comprehensive pathology of calcinosis cutis: types, histopathology, clinical features and diagnostic insights for dermatologists.
Calcinosis cutis refers to the abnormal deposition of calcium salts in the skin and subcutaneous tissues, manifesting as firm papules, nodules, or plaques. This condition spans a spectrum from incidental findings to severe, debilitating lesions associated with systemic diseases, classified into dystrophic, metastatic, idiopathic, iatrogenic, and calciphylaxis types.
Introduction
Calcinosis cutis is an uncommon dermatological disorder characterized by calcium phosphate deposition, often hydroxyapatite or amorphous forms, in normal or damaged tissues. While benign forms may be asymptomatic, severe cases link to connective tissue diseases like systemic sclerosis or dermatomyositis, leading to pain, ulceration, and functional impairment. Pathologically, it arises from local tissue injury or systemic metabolic derangements, with histopathology revealing basophilic calcium deposits surrounded by inflammatory reactions.
The prevalence varies; dystrophic calcinosis is most common, affecting up to 20-40% of juvenile dermatomyositis patients and CREST syndrome cases. Understanding its pathology is crucial for accurate diagnosis and management, as it influences therapeutic approaches from conservative to surgical.
Clinical Features
The presentation of calcinosis cutis depends on subtype and underlying etiology. Lesions typically evolve gradually as firm, white-to-yellowish papules, plaques, or nodules, ranging from millimeters to centimeters. They may remain symptomless or become tender, ulcerate, and discharge chalky, creamy material composed of calcium phosphate and carbonate.
- Solitary vs. multiple lesions: Single nodules occur but clusters are frequent, especially in extremities.
- Pain and functional impact: Fingertip lesions cause significant pain; larger deposits restrict joint mobility via skin stiffening.
- Complications: Severe cases lead to ulceration, secondary infection, tissue necrosis, or cutaneous gangrene, particularly in calciphylaxis.
Localization correlates with cause: dystrophic types favor elbows, knees, forearms in scleroderma; metastatic around joints symmetrically; calciphylaxis prefers fatty trunk areas. In children, subepidermal calcified nodules appear on head and extremities.
Classification
Calcinosis cutis is categorized into five major types based on etiology, calcium-phosphate homeostasis, and tissue status.
| Type | Calcium/Phosphate Levels | Key Associations | Pathological Mechanism |
|---|---|---|---|
| Dystrophic | Normal | Trauma, inflammation, connective tissue diseases (scleroderma, dermatomyositis) | Tissue damage releases phosphate-binding proteins, leading to local calcification |
| Metastatic | Elevated | Chronic kidney disease, hyperparathyroidism, vitamin D excess | Systemic hypercalcemia/hyperphosphatemia deposits in normal tissues |
| Idiopathic | Normal | Scrotal calcinosis, tumoral calcinosis | Unknown; no preceding damage |
| Iatrogenic | Normal | IV calcium extravasation, electrode pastes | Direct calcium salt precipitation in skin |
| Calciphylaxis | Often elevated | End-stage renal disease, warfarin use | Vascular calcification with ischemia and necrosis |
Dystrophic Calcinosis Cutis
The most prevalent form, occurring in damaged tissues without serum abnormalities. Associated with autoimmune diseases (CREST, juvenile dermatomyositis), infections, neoplasms, or trauma. Deposits form due to hypoxic inflammation and phosphate release from necrotic cells. Common sites: periarticular areas in scleroderma.
Metastatic Calcinosis Cutis
Results from hypercalcemia/hyperphosphatemia, depositing in normal skin. Primary causes include chronic kidney failure (most common), hyperparathyroidism, sarcoidosis, milk-alkali syndrome, and Paget disease. Lesions symmetric around joints or visceral.
Idiopathic Calcinosis Cutis
No identifiable cause or metabolic abnormality. Subtypes include scrotal calcinosis (young males, painless scrotal nodules) and tumoral calcinosis (large periarticular masses, often familial).
Iatrogenic and Traumatic Calcinosis Cutis
Iatrogenic from calcium-containing IV leaks or electrode gels, forming tender swellings. Traumatic from repetitive injury, e.g., in coal miners or oil workers.
Calciphylaxis
A life-threatening variant with painful, mottled plaques progressing to necrosis, mainly in dialysis patients.
Histopathology
Biopsy confirms diagnosis, showing calcium deposits as basophilic granules or chunky masses in dermis/subcutis, staining blue with H&E and black with von Kossa. Surrounding features include:
- Foreign-body giant cell reaction and chronic inflammation.
- Fibrosis in chronic lesions.
- Vascular calcification and thrombosis in calciphylaxis.
- Amorphous hydroxyapatite in dystrophic type.
In dystrophic cases, deposits lie in damaged collagen; metastatic shows perivascular involvement. Subepidermal nodules in children feature dermal calcifications without epidermal change.
Diagnosis
Diagnosis integrates clinical, radiological, and histopathological findings.
- Laboratory: Serum calcium, phosphate, PTH, renal function to classify type.
- Imaging: X-rays show radiopaque deposits; CT/ultrasound delineate extent; bone scintigraphy detects early uptake.
- Biopsy: Gold standard for confirmation and subtype.
Differential includes gouty tophi, cysts, or neoplasms; polarization helps exclude crystals.
Pathogenesis
Dystrophic: Tissue injury induces apoptosis, releasing membrane-bound proteins that bind phosphate, nucleating hydroxyapatite under alkaline conditions from lactic acid depletion. Metastatic: Supersaturated calcium-phosphate product precipitates systemically. Idiopathic may involve local osteogenic differentiation. Vascular factors like hypoxia exacerbate all types.
Treatment
No universal cure; focus on underlying cause and symptom relief.
- Medical: Bisphosphonates, diltiazem, colchicine, warfarin, IVIG show variable efficacy.
- Physical: Intralesional steroids, laser therapy, shockwave.
- Surgical: Excision for symptomatic, accessible lesions; risks recurrence.
Prognosis varies; benign in idiopathic, poor in calciphylaxis (50-80% mortality).
Frequently Asked Questions (FAQs)
What is calcinosis cutis?
Calcium salt deposition in skin/subcutis, classified by etiology into dystrophic (most common), metastatic, etc.
Is calcinosis cutis painful?
Often asymptomatic but can cause pain, ulceration, or joint restriction depending on site and size.
How is dystrophic calcinosis treated?
Treat underlying disease; options include diltiazem, surgery for symptomatic lesions.
Can calcinosis cutis be cured?
Not always; management controls symptoms, prevents progression.
What causes metastatic calcification?
Hypercalcemia from renal failure, hyperparathyroidism, vitamin D excess.
References
- Calcification of the skin and subcutaneous tissues — PCDS. 2021-06-08. https://www.pcds.org.uk/clinical-guidance/calcification-of-the-skin-and-subcutaneous-tissues
- Calcinosis Cutis — DermNet NZ. N/A. https://dermnetnz.org/topics/calcinosis-cutis
- Calcinosis cutis — Wikipedia. N/A. https://en.wikipedia.org/wiki/Calcinosis_cutis
- Calcinosis Cutis: Treatment, Diagnosis, Causes, and Symptoms — Healthline. N/A. https://www.healthline.com/health/calcinosis-cutis
- Calcinosis Cutis — StatPearls, NCBI Bookshelf. 2023-04-23. https://www.ncbi.nlm.nih.gov/books/NBK448127/
- Calcinosis cutis — VisualDx. N/A. https://www.visualdx.com/visualdx/diagnosis/calcinosis+cutis?diagnosisId=51238&moduleId=101
Similar Articles
Read full bio of Sneha Tete
